FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical composition for injection targeted local application which involves a sterile suspension of platinum complex (OC-6-43)-bis(acetato)-(1-adamantilamino)ammine-dichloroplatinum (IV) (LA-12) in a pharmaceutically acceptable hydrophilic or hydrophobic injection liquid phase with 100% of platinum complex particles sizing less than 250 mcm.
EFFECT: invention provides preparing the sterile platinum complex suspension LA-12 suitable for injection application and containing a sufficient therapeutically effective amount of the complex.
13 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2430718C2 |
| PLATINUM COMPLEX COMPOUNDS, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2200164C2 |
| PHARMACEUTICAL COMPOSITION FOR INJECTIONS | 2007 |
|
RU2443432C2 |
| PLATINUM (IV) COMPLEXES WITH HIGH ANTITUMOR EFFICIENCY | 2014 |
|
RU2666898C1 |
| NEW PLATINUM IV COMPLEXES WITH ESSENTIALLY INCREASED ANTITUMOR EFFICIENCY | 2019 |
|
RU2802514C1 |
| PLATINUM COMPLEX COMPOUNDS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1999 |
|
RU2203901C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX OF PLATINUM AS ACTIVE SUBSTANCE, AND METHOD OF ITS OBTAINING | 2004 |
|
RU2343913C2 |
| PHARMACEUTICAL COMPOSITION AND METHOD FOR PULMONARY ADMINISTRATION THEREOF | 2010 |
|
RU2445119C2 |
| METHOD OF OBTAINING CIS-DIAMMONIUM-DICHLORODIHYDROXOPLATINUM (IV) AND ITS APPLICATION | 2004 |
|
RU2345086C2 |
| SUSPENSION COMPOSITIONS OF HIGHLY CONCENTRATED DISPERSIONS | 2019 |
|
RU2804658C2 |
